Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Budgets $48.6 Million to Monitor H7N9 Bird Flu

publication date: May 1, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
In an emergency declaration, China’s Ministry of Finance allocated 303 million RMB ($48.6 million) in an effort to control the spread of the H7N9 avian flu. The money will fund efforts to monitor cases of H7N9 infection, influenza-like illnesses, severe acute respiratory infection and unexplained pneumonia. Separately, the Ministry of Human Resources and Social Security ordered medical insurance programs to cover more medicine and services for people infected with H7N9, reducing the financial burden on patients. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
ChinaBio Leadership Retreat 2014
Suzhou, China
October 23-24, 2014
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors